Tertiary prevention strategies for micrometastatic lymph node cervical cancer : A systematic review and a prototype of an adapted model of care
Copyright © 2024 Elsevier B.V. All rights reserved..
PURPOSE: We found a need for balancing the application of clinical guidelines and tailored approaches to follow-up of cervical cancer (CC) patients in the lymph node micrometastatic (MICs) setting. This review aimed to determine the current knowledge of management of MIC-positive CC cases.
METHODOLOGY: We addressed prognostic and risk of recurrence monitoring impacts associated with MIC+ cases. The electronic databases for literature and relevant articles were analysed.
RESULTS: Fifteen studies, (4882 patients), were included in our systematic review. While the results show that MICs significantly worsen prognosis in early CC. A tertiary prevention algorithm for low volume lymph node disease may stratify follow-up according to the burden of nodal disease and provide data that helps improve follow-up performance.
CONCLUSION: MICs worsen prognosis and should be managed as suggested by the algorithm. However, this algorithm must be externally validated. The clinical impact of isolated tumor cells (ITC) remains unclear.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:197 |
|---|---|
| Enthalten in: |
Critical reviews in oncology/hematology - 197(2024) vom: 23. Mai, Seite 104329 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Śniadecki, Marcin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Algorithm |
|---|
| Anmerkungen: |
Date Completed 01.05.2024 Date Revised 01.05.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.critrevonc.2024.104329 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370171462 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370171462 | ||
| 003 | DE-627 | ||
| 005 | 20240503000440.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.critrevonc.2024.104329 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1395.xml |
| 035 | |a (DE-627)NLM370171462 | ||
| 035 | |a (NLM)38527594 | ||
| 035 | |a (PII)S1040-8428(24)00072-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Śniadecki, Marcin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tertiary prevention strategies for micrometastatic lymph node cervical cancer |b A systematic review and a prototype of an adapted model of care |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.05.2024 | ||
| 500 | |a Date Revised 01.05.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
| 520 | |a PURPOSE: We found a need for balancing the application of clinical guidelines and tailored approaches to follow-up of cervical cancer (CC) patients in the lymph node micrometastatic (MICs) setting. This review aimed to determine the current knowledge of management of MIC-positive CC cases | ||
| 520 | |a METHODOLOGY: We addressed prognostic and risk of recurrence monitoring impacts associated with MIC+ cases. The electronic databases for literature and relevant articles were analysed | ||
| 520 | |a RESULTS: Fifteen studies, (4882 patients), were included in our systematic review. While the results show that MICs significantly worsen prognosis in early CC. A tertiary prevention algorithm for low volume lymph node disease may stratify follow-up according to the burden of nodal disease and provide data that helps improve follow-up performance | ||
| 520 | |a CONCLUSION: MICs worsen prognosis and should be managed as suggested by the algorithm. However, this algorithm must be externally validated. The clinical impact of isolated tumor cells (ITC) remains unclear | ||
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Algorithm | |
| 650 | 4 | |a Cervical cancer | |
| 650 | 4 | |a Micrometastasis | |
| 650 | 4 | |a Prevention | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Sentinel lymph node | |
| 700 | 1 | |a Guani, Benedetta |e verfasserin |4 aut | |
| 700 | 1 | |a Jaworek, Paulina |e verfasserin |4 aut | |
| 700 | 1 | |a Klasa-Mazurkiewicz, Dagmara |e verfasserin |4 aut | |
| 700 | 1 | |a Mahiou, Katia |e verfasserin |4 aut | |
| 700 | 1 | |a Mosakowska, Karolina |e verfasserin |4 aut | |
| 700 | 1 | |a Buda, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Poniewierza, Patryk |e verfasserin |4 aut | |
| 700 | 1 | |a Piątek, Olga |e verfasserin |4 aut | |
| 700 | 1 | |a Crestani, Adrien |e verfasserin |4 aut | |
| 700 | 1 | |a Stasiak, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Balaya, Vincent |e verfasserin |4 aut | |
| 700 | 1 | |a Musielak, Oliwia |e verfasserin |4 aut | |
| 700 | 1 | |a Piłat, Luiza |e verfasserin |4 aut | |
| 700 | 1 | |a Maliszewska, Karolina |e verfasserin |4 aut | |
| 700 | 1 | |a Aristei, Cynthia |e verfasserin |4 aut | |
| 700 | 1 | |a Guzik, Paweł |e verfasserin |4 aut | |
| 700 | 1 | |a Wojtylak, Szymon |e verfasserin |4 aut | |
| 700 | 1 | |a Liro, Marcin |e verfasserin |4 aut | |
| 700 | 1 | |a Gaillard, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Kocian, Roman |e verfasserin |4 aut | |
| 700 | 1 | |a Gołąbiewska, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Chmielewska, Zuzanna |e verfasserin |4 aut | |
| 700 | 1 | |a Wydra, Dariusz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Critical reviews in oncology/hematology |d 1996 |g 197(2024) vom: 23. Mai, Seite 104329 |w (DE-627)NLM012606006 |x 1879-0461 |7 nnns |
| 773 | 1 | 8 | |g volume:197 |g year:2024 |g day:23 |g month:05 |g pages:104329 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.critrevonc.2024.104329 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 197 |j 2024 |b 23 |c 05 |h 104329 | ||